Solitary huge hepatocellular carcinomas 10 cm or larger may be completely ablated by repeated radiofrequency ablation combined with chemoembolization: Initial experience with 9 patients

Molecular Medicine Reports

Volumn 5, Issue 3, 2012, Pages 832-836

  Ke, Shan ^a   Ding, Xuemei ^a   Gao, Jun ^a   Gao, Kun ^a   Qian, Xiaojun ^a   Cao, Baoxing ^a   Li, Mingying ^a   Sun, Wenbing ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Chemoembolizations; Hepatocellular carcinoma; Huge; Radiofrequency ablation; Solitary

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL ARTICLE; FEMALE; HUMAN; LIVER CELL CARCINOMA; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; RADIOFREQUENCY ABLATION; REPEAT PROCEDURE; RETROSPECTIVE STUDY; SOLITARY HUGE HEPATOCELLULAR CARCINOMA; SURVIVAL RATE; SURVIVAL TIME; TUMOR VOLUME;

AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CHEMOEMBOLIZATION, THERAPEUTIC; COMBINED MODALITY THERAPY; EPIRUBICIN; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84863066950     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2011.708     Document Type: Article

References (28)

1. Rahbari NN, Mehrabi A, Mollberg NM, et al: Hepatocellular carcinoma: current management and perspectives for the future. Ann Surg 253: 453-469, 2011.
2. Yang LY, Fang F, Ou DP, et al: Solitary large hepatocellular carcinoma: a specific subtype of hepatocellular carcinoma with good outcome after hepatic resection. Ann Surg 249: 118-123, 2009.
3. Abdel-Wahab M, Sultan A, el-Ghawalby A, et al: Is resection for large hepatocellular carcinoma in cirrhotic patients beneficial? Study of 38 cases. Hepatogastroenterology 48: 757-761, 2001. (Pubitemid 32619677)
4. Poon RT, Ngan H, Lo CM, et al: Transarterial chemoembolization for inoperable hepatocellular carcinoma and postresection intrahepatic recurrence. J Surg Oncol 73: 109-114, 2000. (Pubitemid 30123735)
5. Mendez-Sanchez N, Vasquez-Fernandez F, Zamora-Valdes D, et al: Sorafenib, a systemic therapy for hepatocellular carcinoma. Ann Hepatol 7: 46-51, 2008. (Pubitemid 351468536)
6. Lau WY, Leung TW, Yu SC, et al: Percutaneous local ablative therapy for hepatocellular carcinoma: a review and look into the future. Ann Surg 237: 171-179, 2003. (Pubitemid 38173243)
7. McGhana JP and Dodd GD III: Radiofrequency ablation of the liver: current status. AJR Am J Roentgenol 176: 3-16, 2001.
8. Livraghi T, Goldberg SN, Lazzaroni S, et al: Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions. Radiology 214: 761-768, 2000. (Pubitemid 30115377)
9. Bruix J and Sherman M: Management of hepatocellular carcinoma. Hepatology 42: 1208-1236, 2005. (Pubitemid 43112690)
10. Sun WB, Wang ZY, Zhang YF, et al: Percutaneous radiofrequency ablation therapy with left single lung ventilation for liver carcinoma in the hepatic dome. Zhonghua Wai Ke Za Zhi 45: 1179-1181, 2007.
11. Matsui O, Kadoya M, Yoshikawa J, et al: Subsegmental transcatheter arterial embolization for small hepatocellular carcinomas: local therapeutic effect and 5-year survival rate. Cancer Chemother Pharmacol 33: S84-S88, 1994. (Pubitemid 24147972)
12. Seror O, N'Kontchou G, Ibraheem M, et al: Large (> or = 5.0 cm) HCCs: multipolar RF ablation with three internally cooled bipolar electrodes - initial experience in 26 patients. Radiology 248: 288-296, 2008.
13. Lau WY and Lai EC: The current role of radiofrequency ablation in the management of hepatocellular carcinoma: a systematic review. Ann Surg 249: 20-25, 2009.
14. Chen MS, Li JQ, Zheng Y, et al: A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 243: 321-328, 2006. (Pubitemid 43327762)
15. Hasegawa K, Kokudo N, Shiina S, et al: Surgery versus radiofrequency ablation for small hepatocellular carcinoma: start of a randomized controlled trial (SURF trial). Hepatol Res 40: 851-852, 2010.
16. Lupo L, Panzera P, Giannelli G, et al: Single hepatocellular carcinoma ranging from 3 to 5 cm: radiofrequency ablation or resection? HPB 9: 429-434, 2007. (Pubitemid 350215037)
17. Kim YS, Rhim H, Lim HK, et al: Intraoperative radiofrequency ablation for hepatocellular carcinoma: long-term results in a large series. Ann Surg Oncol 15: 1862-1870, 2008.
18. Meijerink MR, van den Tol P, van Tilborg AA, et al: Radiofrequency ablation of large size liver tumours using novel plan-parallel expandable bipolar electrodes: initial clinical experience. Eur J Radiol 77: 167-171, 2011.
19. Hirooka M, Koizumi Y, Kisaka Y, et al: Mass reduction by radiofrequency ablation before hepatic arterial infusion chemotherapy improved prognosis for patients with huge hepatocellular carcinoma and portal vein thrombus. AJR Am J Roentgenol 194: W221-W226, 2010.
20. Kim JH, Won HJ, Shin YM, et al: Medium-sized (3.1-5.0 cm) hepatocellular carcinoma: transarterial chemoembolization plus radiofrequency ablation versus radiofrequency ablation alone. Ann Surg Oncol 18: 1624-1629, 2011.
21. Georgiades CS, Hong K and Geschwind JF: Radiofrequency ablation and chemoembolization for hepatocellular carcinoma. Cancer J 14: 117-122, 2008.
22. Veltri A, Moretto P, Doriguzzi A, et al: Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC). Eur Radiol 16: 661-669, 2006. (Pubitemid 44149378)
23. Buscarini L, Buscarini E, Di Stasi M, et al: Percutaneous radiofrequency thermal ablation combined with transcatheter arterial embolization in the treatment of large hepatocellular carcinoma. Ultraschall Med 20: 47-53, 1999. (Pubitemid 29215291)
24. Sun WB, Ding XM, Ke S, et al: Repeated radiofrequency ablation as both salvage solution and curative treatment for spontaneous rupture of giant medial lobe hepatocellular carcinoma. Chin Med J 122: 2067-2070, 2009.
25. Ke S, Ding XM, Kong J, et al: Low temperature of radiofrequency ablation at the target sites can facilitate rapid progression of residual hepatic VX2 carcinoma. J Transl Med 8: 73, 2010.
26. Zerbini A, Pilli M, Penna A, et al: Radiofrequency thermal ablation of hepatocellular carcinoma liver nodules can activate and enhance tumor-specific T-cell responses. Cancer Res 66: 1139-1146, 2006. (Pubitemid 43165983)
27. Zerbini A, Pilli M, Fagnoni F, et al: Increased immunostimulatory activity conferred to antigen-presenting cells by exposure to antigen extract from hepatocellular carcinoma after radiofrequency thermal ablation. J Immunother 31: 271-282, 2008. (Pubitemid 351440997)
28. Greten TF and Korangy F: Radiofrequency ablation for the treatment of HCC - maybe much more than simple tumor destruction? J Hepatol 53: 775-776, 2010.